Cardio-Immuno-Oncology-Reference-Cited by-同舟云学术

Cardio-Immuno-Oncology

Published:2020-01-14 Issue:2 Volume:141 Page:87-89
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Zaha Vlad G.¹,Meijers Wouter C.²,Moslehi Javid²

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, Advanced Imaging Research Center, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas (V.G.Z.).

2. Division of Cardiovascular Medicine and Oncology, Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (W.C.M., J.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Cardiovascular Toxic Effects of Targeted Cancer Therapies

2. Comprehensive analysis of the clinical immuno-oncology landscape

3. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

4. Immunotherapy for cardiovascular disease (published online May 23, 2019).;Lutgens E;Eur Heart J

5. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study;Frontiers in Immunology;2024-09-11

2. Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology;Genes & Diseases;2024-03

3. Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure;Nature Reviews Cardiology;2024-01-26

4. Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study;Therapeutic Advances in Medical Oncology;2024-01

5. Risk profiles and incidence of cardiovascular events across different cancer types;ESMO Open;2023-12